Actively Recruiting

Age: 2Years - 8Years
All Genders
NCT06191640

Sinus Disease in Young Children With Cystic Fibrosis

Led by University of California, Los Angeles · Updated on 2026-05-11

80

Participants Needed

6

Research Sites

324 weeks

Total Duration

On this page

Sponsors

U

University of California, Los Angeles

Lead Sponsor

U

University of Kansas Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a prospective, observational study examining the impact of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators on chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) in young children with cystic fibrosis (YCwCF). This study involves two groups: children 2-8 years old, inclusive at initial visit, receiving highly effective modulator therapy (HEMT), and a control group of children 2-8 years old, inclusive at initial visit, not receiving HEMT. Outcomes will include sinus magnetic resonance imaging (MRI) scans, olfactory tests, and quality of life surveys obtained over a two-year period.

CONDITIONS

Official Title

Sinus Disease in Young Children With Cystic Fibrosis

Who Can Participate

Age: 2Years - 8Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children with confirmed cystic fibrosis diagnosis
  • Age 2 to 8 years at first study visit
  • For HEMT group: CFTR mutation eligible for ivacaftor or elexacaftor/tezacaftor/ivacaftor and planned prescription before starting treatment
  • For control group: Ineligible for HEMT due to CFTR mutation or clinical decision not to start HEMT
Not Eligible

You will not qualify if you...

  • Use of an investigational drug within 28 days before first study visit
  • Use of ivacaftor or elexacaftor/tezacaftor/ivacaftor within 180 days before and including first study visit
  • Use of chronic oral corticosteroids within 28 days before and including first study visit
  • Sinus surgery within 180 days before first study visit

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

2

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

3

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

Actively Recruiting

4

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229-3039

Actively Recruiting

5

University of Vermont

Colchester, Vermont, United States, 05446

Actively Recruiting

6

University of Virginia

Charlottesville, Virginia, United States, 22903

Actively Recruiting

Loading map...

Research Team

D

Daniel M Beswick, MD

CONTACT

M

Marlene Florian

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here